<bill session="109" type="h" number="1650" updated="2021-04-20T19:27:42Z">
  <state datetime="2005-04-14">REFERRED</state>
  <status>
    <introduced datetime="2005-04-14"/>
  </status>
  <introduced datetime="2005-04-14"/>
  <titles>
    <title type="short" as="introduced">Stem Cell Research Investment Act of 2005</title>
    <title type="display">Stem Cell Research Investment Act of 2005</title>
    <title type="official" as="introduced">To amend the Internal Revenue Code of 1986 to allow tax credits to holders of stem cell research bonds.</title>
  </titles>
  <sponsor bioguide_id="J000163"/>
  <cosponsors>
    <cosponsor bioguide_id="B000652" joined="2005-04-14"/>
    <cosponsor bioguide_id="C000243" joined="2005-04-14"/>
    <cosponsor bioguide_id="C000380" joined="2005-04-14"/>
    <cosponsor bioguide_id="F000238" joined="2005-04-27"/>
    <cosponsor bioguide_id="L000551" joined="2005-04-14" withdrawn="2005-05-12"/>
    <cosponsor bioguide_id="R000033" joined="2005-04-14"/>
    <cosponsor bioguide_id="S000030" joined="2005-04-14"/>
    <cosponsor bioguide_id="S001144" joined="2005-04-14"/>
    <cosponsor bioguide_id="S001152" joined="2005-04-14"/>
  </cosponsors>
  <actions>
    <action datetime="2005-04-14">
      <text>Introduced in House</text>
    </action>
    <action datetime="2005-04-14" state="REFERRED">
      <text>Referred to the House Committee on Ways and Means.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Taxation"/>
    <term name="Cytology"/>
    <term name="Donation of organs, tissues, etc."/>
    <term name="Economics and Public Finance"/>
    <term name="Finance and Financial Sector"/>
    <term name="Genetic research"/>
    <term name="Government Operations and Politics"/>
    <term name="Government paperwork"/>
    <term name="Government securities"/>
    <term name="Health"/>
    <term name="Human embryology"/>
    <term name="Income tax"/>
    <term name="Informed consent (Medical law)"/>
    <term name="Interest"/>
    <term name="Law"/>
    <term name="Medical research"/>
    <term name="Science, Technology, Communications"/>
    <term name="Tax credits"/>
    <term name="Tax returns"/>
  </subjects>
  <amendments/>
  <summary date="2005-05-10T18:33:33Z" status="Introduced in House">Stem Cell Research Investment Act of 2005 - Amends the Internal Revenue Code to allow a tax credit for investment in qualified stem cell research bonds. Defines "qualified stem cell research bond" as any bond issued by a State or local government, 95 percent of the proceeds of which are to be used for interdisciplinary scientific and medical research relating to stem cells, therapy development relating to stem cells, and development of pharmacologies and treatments through clinical trials relating to stem cells. Imposes certain limitations on the use of stem cells that are supported by a bond issuance under this Act.

Sets a national limitation in 2006 through 2008 of $10 billion on the issuance of stem cell research bonds. Terminates the authority to issue such bonds after FY 2008.</summary>
</bill>
